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Molecular chaperones: Inside and outside the Anfinsen cage
R. John Ellis 
The GroEL/GroES chaperonin system acts as a passive
anti-aggregation cage for refolding rubisco and
rhodanese, and not as an active unfolding device.
Refolding aconitase is too large to enter the cage but
reversible binding to GroEL reduces its aggregration.
Unexpectedly, confinement in the cage increases the
rate of refolding of rubisco, but not rhodanese. 
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The bacterial chaperonin system GroEL/GroES assists the
completion of folding of some partly folded polypeptide
chains after their release from ribosomes. Since this prop-
erty was discovered [1], unravelling its mechanism has gen-
erated much ingenious experimentation. Two different
types of mechanism were discussed from the outset. One
suggests that the central cage of each double-ring GroEL
oligomer acts as a passive sequestration chamber, inside
which one partly folded polypeptide chain continues to fold,
protected from the hazard of forming a non-functional
aggregate with one or more similar chains [2,3]. The other
suggests that the GroEL/GroES system actively unfolds
misfolded chains, and so allows them another chance to
fold correctly [4].
Neither of these two mechanisms conflicts with the
principle of protein self-assembly, espoused originally by
Caspar and Klug for viruses [5] and by Anfinsen for the
refolding of denatured polypeptides [6]. Rather, they offer
different, but not mutually exclusive, ways to explain how
the GroEL/GroES system improves the efficiency with
which the steric information encoded in the primary struc-
ture of a newly synthesized polypeptide creates a correctly
folded protein. Recent work from the Hartl and Hayer-
Hartl laboratory [7] favours the passive cage model over
the active unfolding model for the two proteins tested, but
also reports the unexpected finding that the rate of folding
of one of these proteins is four-fold faster inside the cage
than outside it. And a new paper from the Horwich labora-
tory [8] reports that the enzyme aconitase is too large to
enter the cage, but that reversible binding to GroEL reduces
its tendency to aggregate.
The term ‘Anfinsen cage’ was introduced to describe the
idea that GroEL improves the efficiency of refolding of
denatured proteins by binding each partly folded chain
inside its oligomeric structure, thereby protecting it from
aggregating with other similar chains [3]. ATP-triggered
release of the bound chain into the cavity of the cage was
suggested to allow it to fold in the same manner as it
would in free solution in a classic Anfinsen refolding exper-
iment. Subsequent in vitro experiments using reconsti-
tuted protein refolding systems in several laboratories
have established that binding of GroES and ATP to the
GroEL oligomer displaces the polypeptide inside the
cage, where it continues to fold. GroES caps the cage to
keep the sequestered chain from emerging into the medium
for a time determined by the rate of ATP hydrolysis. If a
chain does not fold sufficiently to internalise its GroEL-
binding sites within about 15 seconds at 25°C, it is released
into the buffer where it may either aggregate with similar
chains or rebind to another GroEL oligomer (reviewed in
[9,10]). Addition of crowding agents to the in vitro system
reduces this release, suggesting that, in vivo, the crowded
state of the cytoplasm ensures any released chain binds
back rapidly to the same GroEL oligomer, and thus min-
imises the chance that it will aggregate with another partly
folded chain ([11] and Figure 1a).
From this evidence, the chaperonins would appear to act
as passive anti-aggregation devices or ‘mini-test tubes’,
inside each of which a single chain can fold. Macromolecu-
lar crowding inside cells strongly favours the aggregation
of some polypeptides as they fold [12], and genetic ablation
of chaperonin activity in Escherichia coli has been shown to
cause some proteins to aggregate [13]. Thus both in vitro
and in vivo evidence supports the view that chaperonins
function to reduce the probability that some newly synthe-
sized polypeptides aggregate before they achieve their
correctly folded conformations, and the Anfinsen cage
model offers a plausible explanation for how they achieve
this. But do chaperonins also actively unfold misfolded
conformations? If they do, is this unfolding an essential
aspect of chaperonin function or is it an epiphenomenon,
an inevitable consequence of the cage mechanism of no
functional significance?
Misfolding is conceptually distinct from aggregation, because
it is usually taken to mean that a chain has reached a partly
folded conformation that is stable enough not to be able to
proceed to its functional conformation on a biologically rel-
evant time scale. The energy landscape model of protein
folding suggests that such misfolded chains form a subset
of partly folded chains and, like them, vary in their suscep-
tibility to aggregation [14]. To what extent misfolding is a
real biological problem other than in disease is not clear,
but the ability to unfold such misfolded conformations
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before they are discharged into the Anfinsen cage might
confer an added usefulness on the chaperonin system.
It has been observed for some proteins refolding in vitro in
the presence of GroEL/GroES in uncrowded buffers that
partly folded chains are released from the GroEL cage into
the buffer after each ATPase cycle. Such chains bind to
other GroEL oligomers and transit through the system
repeatedly until they achieve the correctly folded state
[15]. Such cycling may be an artefact of using uncrowded
buffers [11,16], but these observations led to the iterative
annealing model of unfolding, which suggests that large
conformational changes in GroEL resulting from the
binding of GroES exert a stretching force that actively
unfolds bound misfolded chains. When released either into
the cavity of the cage or into the buffer, these unfolded
chains are suggested to have more opportunities to find
routes to correct folding than if they remained misfolded,
and thus they fold more rapidly ([17,18] and Figure 1b).
In support of the unfolding aspect of this model, hydrogen
exchange measurements have detected partial unfolding
of bound chains of bacterial ribulose bis-phosphate
carboxylase (rubisco) during a single reaction cycle [19]. In
contrast, no significant unfolding was found in a nuclear
magnetic resonance (NMR) analysis of refolding malate
dehydrogenase [20]. It is thus relevant to this debate that
the recent work by Brinker et al. [7] employed bacterial
rubisco as one of two protein substrates studied, the other
being rhodanese. Both these substrates are prone to
aggregation, and recycle repeatedly in the GroEL/GroES
system in uncrowded buffers.
There are two testable differences between the cage and
annealing models. In the cage model, the polypeptide must
fold within the cage to avoid aggregation, while in the
latter this is not the case. And the annealing model pre-
dicts that, under conditions where aggregation does not
occur, the rate of correct folding will be faster once unfold-
ing has taken place, while the cage model implies it will be
the same. To distinguish experimentally between these pos-
sibilities, Brinker et al. [7] coupled biotin to cysteine residues
located at the apical domain of GroEL. This modification
does not prevent the normal functioning of the chaperonin
system, but provides a method of preventing released chains
from rebinding to GroEL, as biotin binds rapidly (t1/2 about
200 ms) and irreversibly (KD about 10–14 M) to streptavidin.
Addition of streptavidin blocks entry to the cage and thus
interrupts chain rebinding well within a single reaction cycle.
Brinker et al. [7] found that, under buffer conditions where
partly folded chains of rubisco readily aggregate, the
addition of streptavidin after several ATPase reaction cycles
blocked rubisco folding completely and instantly. This
Figure 1
(a) The Anfinsen cage model of GroEL/GroES action. A partly folded
chain (P) binds to the apical domains of a GroEL oligomer (represented
in red as a vertical slice through two stacked rings of seven subunits
each). Binding of ATP and GroES — a single ring heptamer indicated in
green — displaces this chain into the Anfinsen cage. After one round of
ATP hydrolysis, the unbinding of GroES, triggered by binding of ATP to
the opposite ring, allows the chain to diffuse into the free solution. If the
chain has folded sufficiently (N) it will not rebind, but if it has not (P), it
rapidly binds back under crowded conditions to the same GroEL
oligomer, and so avoids aggregating with other partly folded chains in
free solution. (b) The iterative annealing model of GroEL/GroES action.
This is as in (a), but in this case displacement of the chain into the cage
is accompanied by mechanical stretching that unfolds the chain further
(*). Any chain that is still partly folded on unbinding of GroES enters the
free solution, where it either completes its folding (#) or rebinds to
another GroEL oligomer for a further round of unfolding.
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observation is inconsistent with the iterative annealing
model, which predicts that some released chains would
fold correctly in free solution, but it is in accord with the
cage model, which predicts that correct folding occurs only
within the cage. This result is not surprising, in view of the
known high propensity of partly folded rubisco chains to
aggregate. Partly folded chains of rhodanese do not
aggregate so rapidly as those of rubisco, and addition of
streptavidin to the rhodanese/GroEl/GroES system was
found to allow some of the released chains to fold cor-
rectly. Experiments with a non-cycling single-ring variant
of GroEL, which binds but does not release GroES,
showed that correct folding of rubisco and rhodanese does
not require the repeated cycles of binding and release
implicit in the iterative annealing model. 
Testing the second prediction required the use of buffer
conditions where released partly folded chains do not aggre-
gate. Addition of streptavidin under these circumstances
does not affect the rate of rhodanese folding, which is the
same as the rate of folding in free solution or in the pres-
ence of the uninhibited GroEL/GroES system. Thus any
unfolding of misfolded rhodanese chains by the chaperonin
system does not result in an acceleration of correct folding.
Similar experiments with rubisco, however, revealed that
the rate of folding of this protein is four-fold faster inside
the cage than outside the cage. This effect is similar to the
enhanced rate of folding of reduced lysozyme caused by
the addition of crowding agents in the absence of the chap-
eronin system [21]. A possible explanation of both these
enhancements is that compaction of unfolded chains is
favoured by confinement in a narrow chamber (rubisco)
and by crowding in free solution (lysozyme). Such effects
are predicted by macromolecular crowding theory [12,22].
The Anfinsen cage is too small to accommodate chains
larger than about 60 kDa. Nevertheless, there is in vivo
evidence that some chains larger than 60 kDa bind tran-
siently to GroEL shortly after synthesis, and mitochondrial
aconitase (82 kDa) was found to aggregate in vivo in yeast
[23] and E. coli [8] cells deficient in either GroEL or GroES.
Chaudhuri et al. [8] found that the in vitro refolding of
denatured aconitase is stimulated four to five-fold by addi-
tion of GroEL/GroES/ATP, but the role of GroES in this
case is distinct from its role in the folding of smaller chains
encapsulated inside the cage. Instead of binding to the
same ring to which the aconitase is bound, GroES binds to
the opposite ring, and this triggers the release of bound
aconitase into the free solution where it folds. This entire
cycle is repeated until the aconitase polypeptide has folded
sufficiently not to rebind to GroEL [8].
These experiments with aconitase were carried out with
uncrowded buffers, but the simplest interpretation is that
repeated binding to and release from GroEL reduces the
probability that partly folded chains of aconitase will aggre-
gate with one another by transiently shielding exposed
hydrophobic areas. In this respect the action of GroEL on
aconitase resembles that of the Hsp 70/40 chaperones and
minichaperones, which are too small to provide Anfinsen
cages, but prevent aggregation by temporarily shielding
hydrophobic areas on partly folded chains [10]. The chap-
eronins continue to spring surprises.
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